「ceoメッセージ」の検索結果
73件:41~45件目を表示
-

お知らせ | 千寿製薬株式会社
December 22, 2025 Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential cation chann
https://www.senju.co.jp/english/news/ -

Supplement business | Business Activities | About Senju | SENJU Pharmaceutical
Wellness items that promote health every day to contribute to the health of all people. Senju Pharmaceutical, as a pioneer of ophthalmic drugs, has long engaged in developing prescription and OTC drug
https://www.senju.co.jp/english/about/business/ec.html -

Overseas Activities | SENJU Pharmaceutical
Eye health and pharmaceutical development have no borders. We engage in international activities with a view to the future of pharmaceuticals, transcending national and corporate boundaries. As we ent
https://www.senju.co.jp/english/global/ -

お知らせ | 千寿製薬株式会社
https://www.senju.co.jp/english/news/javascipt: void(0); -

NewMytear CL Ice Refresh | OTC Products, etc. | Products | SENJU Pharmaceutical
Category 3 OTC medicines New Mytear® CL Ice Refresh Nice and comfortable feeling lasting a long time *Powerfully cool CHARACTERISTICS This medicine can be used while wearing all types of contact lense
https://www.senju.co.jp/english/products/mytearir.html